Irisin promotes cardiac progenitor cell‐induced myocardial repair and functional improvement in infarcted heart
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Irisin, a newly identified hormone and cardiokine, is critical for modulating body metabolism. New evidence indicates that irisin protects the heart against myocardial ischemic injury. However, whether irisin enhances cardiac progenitor cell (CPC)‐induced cardiac repair remains unknown. This study examines the effect of irisin on CPC‐induced cardiac repair when these cells are introduced into the infarcted myocardium. Nkx2.5+ CPC stable cells were isolated from mouse embryonic stem cells. Nkx2.5 + CPCs (0.5 × 10 6) were reintroduced into the infarcted myocardium using PEGlylated fibrin delivery. The mouse myocardial infarction model was created by permanent ligation of the left anterior descending (LAD) artery. Nkx2.5 + CPCs were pretreated with irisin at a concentration of 5 ng/ml in vitro for 24 hr before transplantation. Myocardial functions were evaluated by echocardiographic measurement. Eight weeks after engraftment, Nkx2.5 + CPCs improved ventricular function as evident by an increase in ejection fraction and fractional shortening. These findings are concomitant with the suppression of cardiac hypertrophy and attenuation of myocardial interstitial fibrosis. Transplantation of Nkx2.5 + CPCs promoted cardiac regeneration and neovascularization, which were increased with the pretreatment of Nkx2.5 + CPCs with irisin. Furthermore, irisin treatment promoted myocyte proliferation as indicated by proliferative markers Ki67 and phosphorylated histone 3 and decreased apoptosis. Additionally, irisin resulted in a marked reduction of histone deacetylase 4 and increased p38 acetylation in cultured CPCs. These results indicate that irisin promoted Nkx2.5 + CPC‐induced cardiac regeneration and functional improvement and that irisin serves as a novel therapeutic approach for stem cells in cardiac repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.002 · Cited by 1,040 · cited 5×
“Irisin was recently identified as a myokine which is produced by the proteolytic processing of the transmembrane receptor, FNDC5 (Huh et al., 2012; Polyzos, Kountouras, Shields, & Mantzoros, 2013).”
BackgroundInfluentialCardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death Strategies
Zhang, M., Methot, D., Poppa, V., Fujio, Y., Walsh, K., & Murry, C. E. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1367 · Cited by 878
Zhang, Y., Li, R., Meng, Y., Li, S., Donelan, W., Zhao, Y., Qi, L., Zhang, M., Wang, X., Cui, T., et al. (2014) · Diabetes · doi:10.2337/db13-1106 · Cited by 733
Self-citationFNDC5/irisin is not only a myokine but also an adipokine
Roca-Rivada, A., Castelao, C., Senin, L. L., Landrove, M. O., Baltar, J., Crujeiras, A. B., Seoane, L. M., Casanueva, F. F., & Pardo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060563 · Cited by 612 · cited 1×
“In addition, irisin is produced in numerous other places, including adipose tissue, liver, parotid gland, and cardiac muscles (Anastasilakis & Mantzoros, 2017; Huh et al., 2012; Kuloglu et al., 2014; Liu et al., 2013; Roca‐Rivada et al., 2013).”
BackgroundSurvival and Development of Neonatal Rat Cardiomyocytes Transplanted into Adult Myocardium
Müller-Ehmsen, J., Whittaker, P., Kloner, R. A., Dow, J. S., Sakoda, T., Long, T. I., Laird, P. W., & Kedes, L. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1491 · Cited by 481 · cited 1×
“However, poor viability (Müller‐Ehmsen et al., 2002; M. Zhang et al., 2001) and an inability to regulate the microenvironment of the transplant area detract from the therapeutic potential of stem cells.”
BackgroundIrisin is inversely associated with intrahepatic triglyceride contents in obese adults
Zhang, H.-J., Zhang, X.-F., Ma, Z.-M., Pan, L.-L., Chen, Z., Han, H.-W., Han, C.-K., Zhuang, X.-J., Lu, Y., Li, X.-J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.030 · Cited by 234 · cited 1×
“…have also been investigated in various pathological disorders (Aydin et al., 2014; Hee Park et al., 2013; Matsuo et al., 2015; Polyzos et al., 2013; Sanchis‐Gomar, Lippi, Mayero, Perez‐Quilis, & García‐Giménez, 2012; Stengel et al., 2013; Vamvini et al., 2013; H. J. Zhang et al., 2013).”
BackgroundJeremic, N., Chaturvedi, P., & Tyagi, S. C. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25450 · Cited by 211
New role of irisin in hepatocytes: the protective effect of hepatic steatosis in vitro
Park, M.-J., Kim, D.-I., Choi, J.-H., Heo, Y.-R., & Park, S.-H. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.010 · Cited by 168 · cited 2×
“…it is likely that irisin can modify the cytokine profile and metabolism of cultured cells to modulate CPC‐derived cardiac repair (D. J. Li, Li, Yuan, Qu, & Wang, 2017; Lu et al., 2015; Park et al., 2015; So & Leung, 2016; Y. Zhang, Li, et al., 2014), which is of interest for future studies.”
BackgroundIrisin: A renaissance in metabolism?
Polyzos, S. A., Kountouras, J., Shields, K., & Mantzoros, C. S. (2013) · Metabolism · doi:10.1016/j.metabol.2013.04.008 · Cited by 131 · cited 2×
“In addition, its clinical implications have also been investigated in various pathological disorders (Aydin et al., 2014; Hee Park et al., 2013; Matsuo et al., 2015; Polyzos et al., 2013; Sanchis‐Gomar, Lippi, Mayero, Perez‐Quilis, & García‐Giménez, 2012; Stengel et al., 2013; Vamvini et al., 2013; H. J. Zhang et al.,…”
BackgroundMatsuo, Y., Gleitsmann, K., Mangner, N., Werner, S., Fischer, T., Bowen, T. S., Kricke, A., Matsumoto, Y., Kurabayashi, M., Schuler, G., et al. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12006 · Cited by 100 · cited 2×
“In addition, its clinical implications have also been investigated in various pathological disorders (Aydin et al., 2014; Hee Park et al., 2013; Matsuo et al., 2015; Polyzos et al., 2013; Sanchis‐Gomar, Lippi, Mayero, Perez‐Quilis, & García‐Giménez, 2012; Stengel et al., 2013; Vamvini et al., 2013; H. J. Zhang et al.,…”
BackgroundSo, W. Y., & Leung, P. S. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.022 · Cited by 83 · cited 1×
“…it is likely that irisin can modify the cytokine profile and metabolism of cultured cells to modulate CPC‐derived cardiac repair (D. J. Li, Li, Yuan, Qu, & Wang, 2017; Lu et al., 2015; Park et al., 2015; So & Leung, 2016; Y. Zhang, Li, et al., 2014), which is of interest for future studies.”
Background
Cited by
Irisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process
Zhang, H., Wu, X., Liang, J., Kirberger, M., & Chen, N. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101680 · Cited by 88
Cosio, P. L., Crespo-Posadas, M., Velarde-Sotres, Á., & Pelaez, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052476 · Cited by 56
Marrano, N., Biondi, G., Borrelli, A., Cignarelli, A., Perrini, S., Laviola, L., Giorgino, F., & Natalicchio, A. (2021) · Biomolecules · doi:10.3390/biom11020286 · Cited by 56
Metadata
- Authors
- Zhao, Y. T., Wang, J., Yano, N., Zhang, L. X., Wang, H., Zhang, S., Qin, G., Dubielecka, P. M., Zhuang, S., Liu, P. Y., Chin, Y. E., & Zhao, T. C.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2018-09
- Volume
- 234
- Issue
- 2
- Pages
- 1671-1681
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2888876244
- Cited by
- 56
- References
- 11
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.